Exagen Inc. (XGN)
USD 5.52
(-4.83%)
USD 5.52
(-4.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.46 Million | -32.14 Million | -20.26 Million | -14.08 Million | -9.71 Million | -9.3 Million |
| Net Income | -23.68 Million | -47.38 Million | -26.85 Million | -16.68 Million | -12.03 Million | -8.01 Million |
| Depreciation & Amortization | 2.16 Million | 1.55 Million | 948 Thousand | 546 Thousand | 591 Thousand | 731 Thousand |
| Deferred income taxes | 407 Thousand | -306 Thousand | 148 Thousand | -106 Thousand | -247 Thousand | 31 Thousand |
| Stock-based compensation | 3.61 Million | 4.7 Million | 4.72 Million | 2.69 Million | 572 Thousand | 114 Thousand |
| Change in working capital | 325 Thousand | 1.67 Million | -61 Thousand | -1.33 Million | 174 Thousand | -3.59 Million |
| Other non-cash items | 2.71 Million | 7.61 Million | 819 Thousand | 805 Thousand | 1.23 Million | 1.42 Million |
| Investing Cash Flow | -804 Thousand | -4.31 Million | -2.42 Million | -455 Thousand | -103 Thousand | -199 Thousand |
| Investments in PPE | -828 Thousand | -4.31 Million | -2.37 Million | -455 Thousand | -403 Thousand | -199 Thousand |
| Acquisitions | 24 Thousand | - | - | - | 300 Thousand | - |
| Investment purchases | - | - | - | - | - | -2 Million |
| Sales/Maturities of investments | - | - | - | - | - | 2 Million |
| Other Investing Activities | 24 Thousand | - | -50 Thousand | - | 300 Thousand | - |
| Financing Cash Flow | -10.63 Million | -489 Thousand | 64.68 Million | -97 Thousand | 68.73 Million | 11.42 Million |
| Debt repayment | -10.93 Million | -696 Thousand | -525 Thousand | -249 Thousand | -138 Thousand | -38 Thousand |
| Dividends payments | - | - | - | - | -6.74 Million | - |
| Common Stock Repurchased | 279 Thousand | -239 Thousand | 390 Thousand | 142 Thousand | 6.74 Million | - |
| Common Stock Issuance | 306 Thousand | 446 Thousand | 65.2 Million | 173 Thousand | 50.44 Million | 2.71 Million |
| Other Financing Activities | 306 Thousand | 446 Thousand | 65.2 Million | 152 Thousand | 11.68 Million | 11.46 Million |
| Accounts receivables | -474 Thousand | 3.57 Million | -744 Thousand | -3.19 Million | 237 Thousand | -2.26 Million |
| Accounts payables | 67 Thousand | 901 Thousand | -655 Thousand | 986 Thousand | 528 Thousand | -824 Thousand |
| Inventory | - | - | - | - | -567 Thousand | -497 Thousand |
| Other working capital | 732 Thousand | -2.8 Million | 1.33 Million | 873 Thousand | -24 Thousand | -8000.00 |
| Cash at beginning of period | 62.39 Million | 99.54 Million | 57.54 Million | 72.18 Million | 13.26 Million | 11.34 Million |
| Cash at end of period | 36.49 Million | 62.59 Million | 99.54 Million | 57.54 Million | 72.18 Million | 13.26 Million |
| Capital Expenditure | -828 Thousand | -4.31 Million | -2.37 Million | -455 Thousand | -403 Thousand | -199 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -25.89 Million | -36.95 Million | 41.99 Million | -14.63 Million | 58.92 Million | 1.92 Million |
| Free Cash Flow | -15.29 Million | -36.46 Million | -22.63 Million | -14.53 Million | -10.11 Million | -9.5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.96 Million | -3.36 Million | -5.57 Million | -23.68 Million | -5.41 Million | -5.01 Million |
| Depreciation & Amortization | 429 Thousand | 458 Thousand | 507 Thousand | 2.16 Million | 605 Thousand | 503 Thousand |
| Deferred income taxes | - | - | 10.2 Million | 407 Thousand | -81 Thousand | 74 Thousand |
| Stock-based compensation | 560 Thousand | 553 Thousand | 763 Thousand | 3.61 Million | 890 Thousand | 978 Thousand |
| Change in working capital | -853 Thousand | -7.04 Million | 10.87 Million | 325 Thousand | 581 Thousand | -7.06 Million |
| Other non-cash items | 1.79 Million | 7.82 Million | -8.42 Million | 2.71 Million | 512 Thousand | 366 Thousand |
| Investing Cash Flow | -136 Thousand | -86 Thousand | -84 Thousand | -804 Thousand | -2000.00 | -322 Thousand |
| Investments in PPE | -136 Thousand | -86 Thousand | -106 Thousand | -828 Thousand | -2000.00 | -324 Thousand |
| Acquisitions | - | - | 22 Thousand | 24 Thousand | - | 2000.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 22 Thousand | 24 Thousand | - | 2000.00 |
| Financing Cash Flow | -226 Thousand | -100 Thousand | -220 Thousand | -10.63 Million | -108 Thousand | -10.24 Million |
| Debt repayment | -226 Thousand | -204 Thousand | -220 Thousand | -10.93 Million | -235 Thousand | -10.24 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 104 Thousand | 127 Thousand | 279 Thousand | - | - |
| Common Stock Issuance | - | 104 Thousand | -306 Thousand | 306 Thousand | 127 Thousand | - |
| Other Financing Activities | - | -65 Thousand | 9.98 Million | 306 Thousand | 127 Thousand | - |
| Accounts receivables | -802 Thousand | -4.35 Million | 10.49 Million | -474 Thousand | -809 Thousand | -6.93 Million |
| Accounts payables | 829 Thousand | -1.64 Million | 1.48 Million | 67 Thousand | 328 Thousand | -430 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -880 Thousand | -1.04 Million | -1.1 Million | 732 Thousand | 1.06 Million | 300 Thousand |
| Cash at beginning of period | 27.26 Million | 36.49 Million | 28.44 Million | 62.39 Million | 31.46 Million | 52.38 Million |
| Cash at end of period | 24.47 Million | 27.26 Million | 36.49 Million | 36.49 Million | 28.44 Million | 31.66 Million |
| Capital Expenditure | -136 Thousand | -86 Thousand | -106 Thousand | -828 Thousand | -2000.00 | -324 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.78 Million | -9.22 Million | 8.04 Million | -25.89 Million | -3.01 Million | -20.71 Million |
| Free Cash Flow | -2.56 Million | -9.12 Million | 8.24 Million | -15.29 Million | -2.91 Million | -10.47 Million |
RKKE
600287
CNND
BIOX
7062
7115